- Home
- GYRO vs FLGC Comparison
GYRO vs FLGC Comparison
Compare GYRO & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRO
- FLGC
- Stock Information
- Founded
- GYRO 1946
- FLGC 2019
- Country
- GYRO United States
- FLGC United States
- Employees
- GYRO N/A
- FLGC N/A
- Industry
- GYRO Building operators
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- GYRO Real Estate
- FLGC Health Care
- Exchange
- GYRO Nasdaq
- FLGC Nasdaq
- Market Cap
- GYRO 16.9M
- FLGC 17.6M
- IPO Year
- GYRO N/A
- FLGC 2021
- Fundamental
- Price
- GYRO $11.34
- FLGC $1.70
- Analyst Decision
- GYRO
- FLGC Strong Buy
- Analyst Count
- GYRO 0
- FLGC 3
- Target Price
- GYRO N/A
- FLGC $6.50
- AVG Volume (30 Days)
- GYRO 3.8K
- FLGC 342.6K
- Earning Date
- GYRO 01-01-0001
- FLGC 11-06-2024
- Dividend Yield
- GYRO N/A
- FLGC N/A
- EPS Growth
- GYRO N/A
- FLGC N/A
- EPS
- GYRO N/A
- FLGC N/A
- Revenue
- GYRO $2,738,019.00
- FLGC $69,006,000.00
- Revenue This Year
- GYRO N/A
- FLGC N/A
- Revenue Next Year
- GYRO N/A
- FLGC $19.90
- P/E Ratio
- GYRO N/A
- FLGC N/A
- Revenue Growth
- GYRO N/A
- FLGC 13.06
- 52 Week Low
- GYRO $7.65
- FLGC $0.63
- 52 Week High
- GYRO $11.38
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- GYRO 90.99
- FLGC 57.41
- Support Level
- GYRO $7.87
- FLGC $1.49
- Resistance Level
- GYRO $8.10
- FLGC $2.11
- Average True Range (ATR)
- GYRO 0.29
- FLGC 0.24
- MACD
- GYRO 0.31
- FLGC -0.01
- Stochastic Oscillator
- GYRO 98.92
- FLGC 43.84
About GYRO Gyrodyne LLC
Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.